Scilex Holding (NASDAQ:SCLXW – Get Free Report)’s share price fell 17.9% during trading on Monday . The stock traded as low as $0.20 and last traded at $0.23. 37,160 shares were traded during trading, an increase of 112% from the average session volume of 17,506 shares. The stock had previously closed at $0.28.
Scilex Price Performance
The firm’s fifty day moving average is $0.43 and its two-hundred day moving average is $0.22.
Scilex Company Profile
Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a prescription lidocaine topical product for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a ready-to-use oral solution for the acute treatment of migraine with or without aura in adults; and GLOPERBA, a liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.
Further Reading
- Five stocks we like better than Scilex
- ETF Screener: Uses and Step-by-Step Guide
- Tesla Earnings Loom: Bulls Eye $600, Bears Warn of $300
- The Risks of Owning Bonds
- Cathie Wood Buys Alibaba and Baidu: Momentum or More Value Ahead?
- Compound Interest and Why It Matters When Investing
- This ETF Weeds Out Small-Cap Underperformers
Receive News & Ratings for Scilex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scilex and related companies with MarketBeat.com's FREE daily email newsletter.
